Published in

American Heart Association, Arteriosclerosis, Thrombosis, and Vascular Biology, 2(26), p. 417-422, 2006

DOI: 10.1161/01.atv.0000199519.37089.a0

Links

Tools

Export citation

Search in Google Scholar

Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Objective— ADP-induced P2y 12 signaling is crucial for formation and stabilization of an arterial thrombus. We demonstrated recently in platelets from healthy subjects that insulin interferes with Ca 2+ increases induced by ADP-P2y 1 contact through blockade of the G-protein G i , and thereby with P2y 12 -mediated suppression of cAMP. Methods and Results— Here we show in patients with type 2 diabetes mellitus (DM2) that platelets have lost responsiveness to insulin leading to increased adhesion, aggregation, and procoagulant activity on contact with collagen. Using Ser 473 phosphorylation of protein kinase B as output for insulin signaling, a 2-fold increase is found in insulin-stimulated normal platelets, but in DM platelets there is no significant response. In addition, DM2 platelets show increased P2y 12 -mediated suppression of cAMP and decreased P2y 12 inhibition by the receptor antagonist AR-C69931MX. Conclusion— The loss of responsiveness to insulin together with increased signaling through P2y 12 might explain the hyperactivity of platelets in patients with DM2.